跳至主要内容
临床试验/CTRI/2019/07/020190
CTRI/2019/07/020190已完成不适用

To study the efficacy and safety of intralesional tranexamic acid for treatment of melasma in male patients

Himachal Pradesh university1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2019年7月26日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
Total reduction in Melasma area severity index,at 4,8,12,16 week

研究概览

简要总结

I am going to treat the  patient of  melasma (only male volunteer) for this study by giving intralesional tranexamic acid  injections in the strength of 25mg/ml with maximum  number of  patients 50. Objective of the study is to evaluate the safety ,efficacy and adverse effects of intralesional tranexamic acid for the  treatment of melasma in male patients. Total of 35 patients has been registered  till date.

研究设计

研究类型
Interventional
分配方式
Other
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
Male

入选标准

  • Healthy volunteer.

排除标准

  • 1 patient with realistic expectations 2 female, 3 bleeding disorders, 4 using any other treatment modalities for melasma in previous 6 months.

结局指标

主要结局

Total reduction in Melasma area severity index,at 4,8,12,16 week

时间窗: 16 weeks

次要结局

  • MASI score at 16 weeks(At 4weeks interval for 4 times total for sixteen Weeks)

研究者

申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验